Combining therapy to reduce cancer-related fatigue in metastatic cancer patients
Official title: Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
Run by M.D. Anderson Cancer Center · NCT06085716 · Data updated 2026-11-12
This study is testing if combining therapy with a placebo can help reduce fatigue in people with metastatic cancer.
Quick facts
| Phase | Phase2; Phase3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | February 16, 2024 |
| Main results expected | August 31, 2027 |
| Study ends | August 31, 2029 |
| Registry record updated | October 19, 2026 |
| Trial ID | NCT06085716 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with incurable metastatic cancer experiencing moderate to severe fatigue.
✕Probably not a fit
Patients with major contraindications to placebo or significant cognitive impairment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of combining psychoeducational interventions with an open-label placebo to alleviate cancer-related fatigue in patients with metastatic cancers. Participants will be assigned to one of three groups: psychoeducational intervention alone, open-label placebo alone, or a combination of both. The primary objective is to determine if the combination therapy is more effective than psychoeducational intervention alone in reducing fatigue, as measured by the FACIT-F scale. Secondary objectives include assessing the impact on quality of life, mood, sleep, cognitive function, and inflammation over a period of three to six months.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life for patients suffering from cancer-related fatigue.
How similar studies have gone: Previous studies have shown promise in using psychoeducational interventions for cancer-related fatigue, suggesting potential for success in this combined approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Be advanced cancer patients or s or have a history of advanced cancer, having fatigue with severity of ≥ 4/10, on a 0-10 scale (Edmonton Symptom Assessment Scale), and presence of fatigue for at least 2 weeks. 2. Have no clinical evidence of cognitive failure as evidenced by treating clinician assessment at screening (Memorial Delirium Assessment Scale of less than 13/30). 3. Be aged 18 years or older. 4. Be willing to complete in-person or telemedicine follow-up visits with research staff, and able to complete Psychoeducational intervention either in person or virtually within Texas. 5. Have a hemoglobin level of ≥8 g/dL within 1 month (+/- 2 weeks) of enrollment. 6. Be able to understand the description of the study and sign a written informed consent. 7. Have a ECOG performance status score of 0 to 2; and 8. Be seen at an outpatient clinic at MD Anderson Cancer Center's (MDA) main campus or its Houston Area Locations (HALs) 9. Able to read, write and speak English Exclusion Criteria: 1. Have a major contraindication to placebo (e.g., allergy or hypersensitivity to study medications or their constituents), or conditions making adherence difficult as determined by the attending physician. 2. Be unable to complete the baseline assessment forms or to understand the recommendations for participation in the study. 3. Be pregnant (as documented in chart) or become pregnant while on study.
Where it's running
-
MD Anderson Cancer Centerr
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Sriram Yennu, MD — M.D. Anderson Cancer Center
- Study coordinator: Sriram Yennu, MD
- Email: syennu@mdanderson.org
- Phone: (713) 792-3938
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Micro-choice-based approach to fatigue management
A small study in Basel will test a new four-day group program using micro-choices to help people with fatigue from multiple causes see if it’s doable, acceptable, and may help daily functioning.
-
HBS-301 for Narcolepsy: daily wakefulness and sleepiness improvement in adults
This Phase 3 study tests HBS-301 vs placebo in adults with narcolepsy to see if it helps with daytime sleepiness, cataplexy, sleepiness, and fatigue.
-
See if Nuvastatic helps with cancer-related fatigue in colon cancer patients on first-line chemotherapy
This trial tests whether Nuvastatic can lessen fatigue in adults with colon cancer who are receiving their first round of chemotherapy, compared to placebo.
-
Balance and gait in multiple sclerosis: linking motion data to function
Researchers will see if precise motion measurements of balance and walking relate to everyday functional tests in adults with MS.
-
Relaxation and breathing techniques to help with breathlessness and tiredness in cancer patients in palliative care
This study tests whether progressive muscle relaxation or deep breathing exercises can reduce dyspnea and fatigue and improve self-care in adults with cancer receiving palliative care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.